Evidence map›Paper›PMID 32968145›Full record

ArticleScientific reports2020

Injectable pre-cultured tissue modules catalyze the formation of extensive functional microvasculature in vivo.

Nicole E Friend, Ana Y Rioja, Yen P Kong, Jeffrey A Beamish, Xiaowei Hong, Julia C Habif, Jonathan R Bezenah, Cheri X Deng, Jan P Stegemann, Andrew J Putnam

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Biofabrication and Characterization of Vascularizing PEG-Norbornene Microgels.Journal of biomedical materials research. Part A · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Nicole E Friend *Department of Biomedical Engineering, University of Michigan, Ann Arbor, USA.
Ana Y Rioja *Department of Biomedical Engineering, University of Michigan, Ann Arbor, USA.
Yen P KongDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, USA.
Jeffrey A BeamishDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, USA.
Xiaowei HongDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, USA.
Julia C HabifDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, USA.
Jonathan R BezenahDepartment of Chemical Engineering, University of Michigan, Ann Arbor, USA.
Cheri X DengDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, USA.
Jan P StegemannDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, USA. jpsteg@umich.edu.
Andrew J PutnamDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, USA. putnam@umich.edu.
University of Michigan–Ann Arbor · US

Funding

Tissue Engineering and RegenerationT32DE007057 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID H. KOHN · 1985 to 2026
$17.3M
Cellular Biotechnology Training Program (CBTP)T32GM008353 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHWENDEMAN, ANNA · 1991 to 2021
$9.3M
RESEARCH TRAINING IN NEPHROLOGYT32DK007378 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PENNATHUR, SUBRAMANIAM · 1986 to 2019
$5.9M
Regulation and Enhancement of Angiogenesis in Dense Fibrin MatricesR01HL085339 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTNAM, ANDREW J · 2007 to 2024
$5.4M
Cellular Biotechnology Training Program (CBTP) - Years 31-35T32GM145304 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Guizhi Zhu · 2022 to 2026
$2.6M
Training Program in Translational Cardiovascular Research and EntrepreneurshipT32HL125242 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MICHELE, DANIEL E · 2015 to 2024
$1.9M
Preformed vascular modules designed for inosculation with host tissueR01HL118259 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTNAM, ANDREW J, STEGEMANN, JAN P. · 2013 to 2016
$1.5M
NHLBI NIH HHS R01 HL085339NHLBI NIH HHS R01 HL118259NHLBI NIH HHS R01-HL118259NHLBI NIH HHS T32 HL125242NHLBI NIH HHS T32-HL125242NIDCR NIH HHS T32 DE007057NIDCR NIH HHS T32-DE007057NIDDK NIH HHS T32 DK007378NIDDK NIH HHS T32-DK007378NIGMS NIH HHS T32 GM008353NIGMS NIH HHS T32-GM008353NIGMS NIH HHS T32 GM145304
6 · The paper itself

Abstract

Revascularization of ischemic tissues is a major barrier to restoring tissue function in many pathologies. Delivery of pro-angiogenic factors has shown some benefit, but it is difficult to recapitulate the complex set of factors required to form stable vasculature. Cell-based therapies and pre-vascularized tissues have shown promise, but the former require time for vascular assembly in situ while the latter require invasive surgery to implant vascularized scaffolds. Here, we developed cell-laden fibrin microbeads that can be pre-cultured to form primitive vascular networks within the modular structures. These microbeads can be delivered in a minimally invasive manner and form functional microvasculature in vivo. Microbeads containing endothelial cells and stromal fibroblasts were pre-cultured for 3 days in vitro and then injected within a fibrin matrix into subcutaneous pockets on the dorsal flanks of SCID mice. Vessels deployed from these pre-cultured microbeads formed functional connections to host vasculature within 3 days and exhibited extensive, mature vessel coverage after 7 days in vivo. Cellular microbeads showed vascularization potential comparable to bulk cellular hydrogels in this pilot study. Furthermore, our findings highlight some potentially advantageous characteristics of pre-cultured microbeads, such as volume preservation and vascular network distribution, which may be beneficial for treating ischemic diseases.

Indexed as

Neovascularization, PhysiologicTissue EngineeringAnimalsCells, CulturedFibrinFibroblastsHumansHuman Umbilical Vein Endothelial CellsHydrogelsMiceMicrospheresMicrovesselsTissue ScaffoldsFibrinHydrogels

Identifiers

PMID32968145
PMCPMC7511337
OpenAlexW3088950165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.